Anna Esteve

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Insulin Resistance

Newly Diagnosed

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Teresa Gorria, Carme Crous, Estela Pineda Losada, Ainhoa Hernandez, Marta Domenech, Carolina Sanz, Pedro Jares, Ana María Muñoz-Mármol, Oriol Arpí-Llucía, Bárbara Melendez, Marta Gut, Anna Esteve, Anna Esteve-Codina, Genis Parra, Francesc Alameda, Cristina Carrato, Iban Aldecoa, Mar Mallo, Nuria de la Iglesia, Carmen Balana
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation. Cancers 16 (4) (2024)
Sandra Fontanals, Anna Esteve, Andrea González, Cristina Ibáñez, Ricard Mesía, Ana Clopés
Real-world treatment outcomes of immune checkpoint inhibitors used off-label in oncology: A comprehensive cancer institution experience. Pharmacology research & perspectives 12 (1) (2024)
Sandra Fontanals, Anna Esteve, Andrea González, Cristina Ibáñez, Ricard Mesía, Ana Clopés
Real-world treatment outcomes of immune checkpoint inhibitors used off-label in oncology: A comprehensive cancer institution experience. Pharmacology research & perspectives 12 (1) (2024)
Teresa Gorria, Carme Crous, Estela Pineda Losada, Ainhoa Hernandez, Marta Domenech, Carolina Sanz, Pedro Jares, Ana María Muñoz-Mármol, Oriol Arpí-Llucía, Bárbara Melendez, Marta Gut, Anna Esteve, Anna Esteve-Codina, Genis Parra, Francesc Alameda, Cristina Carrato, Iban Aldecoa, Mar Mallo, Nuria de la Iglesia, Carmen Balana
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation. Cancers 16 (4) (2024)
Andrea Plaja, Iris Teruel, Maria Ochoa-de-Olza, Marc Cucurull Salamero, Álvaro Javier Arroyo, Beatriz Pardo, Irene Ortiz, Marta Gil-Martin, Josep María Piulats, Helena Pla, Claudia Fina, Anna Carbó, Maria-Pilar Barretina-Ginesta, Sergio Martínez-Román, Elvira Carballas, Andrea González, Anna Esteve, Margarita Romeo Marin
Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery. International journal of molecular sciences 24 (14) (2023)
Sandra Fontanals, Anna Esteve, Andrea González, Cristina Ibáñez, Javier Martínez, Ricard Mesía, Ana Clopés
Real-world treatment outcomes of medicines used in special situations (off-label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution. Cancer medicine (2023)
Margarita Romeo Marin, Marta Gil-Martín, Lydia Gaba, Iris Teruel, Álvaro Taus, Claudia Fina, Maria Masvidal, Paola Murata, Julen Fernández-Plana, Alejandro Martínez, Cristina Pérez, Yolanda García, Valerie Rodriguez, Sara Cros, Marta Parera, Montserrat Zanui, Silvia Catot, Beatriz Pardo, Andrea Plaja, Anna Esteve, Maria Pilar Barretina-Ginesta
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting. Cancers 14 (18) (2022)
Carmen Balaña Quintero, Chen Sun, María Angeles Vaz Salgado, Anna Esteve
Reply to: Extended adjuvant temozolomide in newly diagnosed glioblastoma: the more, the better? Neuro-oncology 23 (9) (2021)
Cristina Carrato, Francesc Alameda, Anna Esteve-Codina, Estela Pineda Losada, Oriol Arpí, Maria Martinez-García, Mar Mallo, Marta Gut, Raquel Lopez-Martos, Sonia Del Barco, Teresa Ribalta, Jaume Capellades, Josep Puig, Oscar Gallego, Carlos Mesia, Ana Maria Muñoz-Marmol, Ivan Archilla, Montserrat Arumí, Julie Marie Blanc, Beatriz Bellosillo, Silvia Menendez, Anna Esteve, Silvia Bagué, Ainhoa Hernandez, Jordi Craven-Bartle, Rafael Fuentes, Noemí Vidal, Iban Aldecoa, Nuria de la Iglesia, Carmen Balana
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)
Anna Esteve-Codina, Francesc Alameda, Cristina Carrato, Estela Pineda Losada, Oriol Arpí, Maria Martinez-García, Mar Mallo, Marta Gut, Marc Dabad, Avelina Tortosa, Sonia Del Barco, Jaume Capellades, Josep Puig, Oscar Gallego, Teresa Pujol, Laura Oleaga, Juan Miguel Gil-Gil, Cristian de Quintana-Schmidt, Izaskun Valduvieco, Anna Martinez-Cardus, Beatriz Bellosillo, Ana Maria Muñoz-Marmol, Anna Esteve, Marta Domenech, Angels Camins, Jordi Craven-Bartle, Salvador Villa, Jordi Marruecos, Nuria de la Iglesia, Carmen Balana
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)